Replimune Stock Forecast - 20 Period Moving Average

REPL Stock  USD 14.08  0.03  0.21%   
The 20 Period Moving Average forecasted value of Replimune Group on the next trading day is expected to be 12.44 with a mean absolute deviation of 0.74 and the sum of the absolute errors of 30.50. Replimune Stock Forecast is based on your current time horizon. Although Replimune's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Replimune's systematic risk associated with finding meaningful patterns of Replimune fundamentals over time.
  
The value of Payables Turnover is estimated to slide to 0.54. The value of Common Stock Shares Outstanding is expected to slide to about 47.1 M. Net Loss is expected to rise to about (100.9 M) this year.
A commonly used 20-period moving average forecast model for Replimune Group is based on a synthetically constructed Replimunedaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Replimune 20 Period Moving Average Price Forecast For the 2nd of December

Given 90 days horizon, the 20 Period Moving Average forecasted value of Replimune Group on the next trading day is expected to be 12.44 with a mean absolute deviation of 0.74, mean absolute percentage error of 0.98, and the sum of the absolute errors of 30.50.
Please note that although there have been many attempts to predict Replimune Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Replimune's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Replimune Stock Forecast Pattern

Backtest ReplimuneReplimune Price PredictionBuy or Sell Advice 

Replimune Forecasted Value

In the context of forecasting Replimune's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Replimune's downside and upside margins for the forecasting period are 6.75 and 18.12, respectively. We have considered Replimune's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
14.08
12.44
Expected Value
18.12
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Replimune stock data series using in forecasting. Note that when a statistical model is used to represent Replimune stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria81.3283
BiasArithmetic mean of the errors -0.3943
MADMean absolute deviation0.7438
MAPEMean absolute percentage error0.0594
SAESum of the absolute errors30.4975
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Replimune Group 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Replimune

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Replimune Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
8.4014.0919.78
Details
Intrinsic
Valuation
LowRealHigh
12.6722.7728.46
Details
8 Analysts
Consensus
LowTargetHigh
47.4252.1157.84
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.82-0.75-0.71
Details

Other Forecasting Options for Replimune

For every potential investor in Replimune, whether a beginner or expert, Replimune's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Replimune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Replimune. Basic forecasting techniques help filter out the noise by identifying Replimune's price trends.

View Replimune Related Equities

 Risk & Return  Correlation

Replimune Group Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Replimune's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Replimune's current price.

Replimune Market Strength Events

Market strength indicators help investors to evaluate how Replimune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Replimune shares will generate the highest return on investment. By undertsting and applying Replimune stock market strength indicators, traders can identify Replimune Group entry and exit signals to maximize returns.

Replimune Risk Indicators

The analysis of Replimune's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Replimune's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting replimune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Replimune to cross-verify your projections.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.04)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.